TP53 Co-Mutations in Advanced EGFR-Mutated Non–Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy

MLA

Surui Liu, et al. “TP53 Co-Mutations in Advanced EGFR-Mutated Non–Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy.” Frontiers in Oncology, vol. 12, Apr. 2022. EBSCOhost, https://doi.org/10.3389/fonc.2022.860563.

APA

Surui Liu, Jin Yu, Hui Zhang, & Jie Liu. (2022). TP53 Co-Mutations in Advanced EGFR-Mutated Non–Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.860563

Chicago

Surui Liu, Jin Yu, Hui Zhang, and Jie Liu. 2022. “TP53 Co-Mutations in Advanced EGFR-Mutated Non–Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy.” Frontiers in Oncology 12 (April). doi:10.3389/fonc.2022.860563.